Gara Jalqabaatti › Dhibee Seli Sikiilii
Qorannoo klinikaalii Dhibee Seli Sikiilii Ameerikaa Keessatti hirmaatuu
Qorannoo 107 Dhibee Seli Sikiilii f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.
Magaalota qorannoo baay'ee qaban
- Atlanta, GAQorannoo 22
- Washington, DCQorannoo 20
- Chicago, ILQorannoo 18
- Memphis, TNQorannoo 18
- Philadelphia, PAQorannoo 15
- Birmingham, ALQorannoo 14
- New York City, NYQorannoo 13
- St. Louis, MOQorannoo 12
- Boston, MAQorannoo 10
- Durham, NCQorannoo 10
- Houston, TXQorannoo 10
- Cincinnati, OHQorannoo 10
- Greenville, NCQorannoo 9
- Columbus, OHQorannoo 9
- Pittsburgh, PAQorannoo 9
- The Bronx, NYQorannoo 8
- Cleveland, OHQorannoo 7
- Charlotte, NCQorannoo 7
- Baltimore, MDQorannoo 7
- Oakland, CAQorannoo 7
- Los Angeles, CAQorannoo 7
- Richmond, VAQorannoo 6
- Nashville, TNQorannoo 6
- Jackson, MSQorannoo 5
- Detroit, MIQorannoo 5
- Hartford, CTQorannoo 5
- Indianapolis, INQorannoo 5
- Phoenix, AZQorannoo 5
- Augusta, GAQorannoo 5
- New Haven, CTQorannoo 4
- Greenville, SCQorannoo 4
- Arlington, VAQorannoo 4
- Milwaukee, WIQorannoo 4
- New Orleans, LAQorannoo 4
- Minneapolis, MNQorannoo 3
- Edison, NJQorannoo 3
- Mobile, ALQorannoo 3
- Rochester, NYQorannoo 3
- Queens, NYQorannoo 3
- Newark, NJQorannoo 3
Naannoon
- AlabamaQorannoo 16
- ArizonaQorannoo 5
- ArkansasQorannoo 3
- CaliforniaQorannoo 19
- ConnecticutQorannoo 7
- DelawareQorannoo 6
- Distaarikii KoloombiyaaQorannoo 10
- FloridaQorannoo 9
- GeorgiaQorannoo 25
- IllinoisQorannoo 19
- IndianaQorannoo 5
- LouisianaQorannoo 5
- MarylandQorannoo 17
- MassachusettsQorannoo 10
- MichiganQorannoo 9
- MinnesotaQorannoo 5
- MississippiQorannoo 5
- MissouriQorannoo 13
- New JerseyQorannoo 8
- New YorkQorannoo 21
- North CarolinaQorannoo 18
- OhioQorannoo 22
- PennsylvaniaQorannoo 20
- South CarolinaQorannoo 6
- TennesseeQorannoo 22
- TexasQorannoo 11
- VirginiaQorannoo 9
- WisconsinQorannoo 4
Qorannoo yeroo dhihootti haaromfaman
Takkalaa qorannoo (Ingiliffa)
A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07187973Exercise in Child Health
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
Umuriin 10 hanga 17 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT05359991Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT03937817A Study of Nicotinamide With Oral Tetrahydrouridine and Decitabine to Treat High Risk Sickle Cell Disease
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT04055818Blood Sampling for Research Related to Sickle Cell Disease
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 18 hanga 100 · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT00542230A Study to Investigate the Effect of Mitapivat on Transfusion Burden in Subjects With Sickle Cell Disease (SCD)
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07656415A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 12 hanga 100 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT06439082Determination of Red Cell Survival in Sickle Cell Disease and Other Hemoglobinopathies Using Biotin Labeling
Namoota walitti qabaa jiraSadarkaa jalqabaa 1
Umuriin 18 hanga 100 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT06313398A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 2 fi ol · Saalaa hunda · Haaromfame 18-Ful-2026 · NCT06609226Dietary Intake and Dietary Behaviors in Adults With Sickle Cell Disease
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 hanga 120 · Saalaa hunda · Haaromfame 18-Ful-2026 · NCT05170412Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in Subjects With Stable Sickle Cell Disease
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT05904093A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT06612268Tocilizumab for Acute Chest Syndrome
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT05640271Sickle Cell Disease Biofluid Chip Technology (SCD BioChip)
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT02824471Study to Understand the Genetic Risk of Developing an Immune Response After Blood Transfusions Among Individuals With Sickle Cell Disease
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 2 hanga 99 · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT06944067Assessing Molecular Mechanisms and Effects of Music Therapy in Youth With Sickle Cell Disease Using Single-cell RNA-sequencing
Namoota walitti qabaa jira
Umuriin 8 hanga 18 · Saalaa hunda · Haaromfame 10-Ful-2026 · NCT07562451Early Screening and Treatment of Heart Complication in Sickle Cell Disease
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT07023666A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Namoota walitti qabaa jiraSadarkaa 1/2Hojjettoota fayyaa simatamoo
Umuriin 12 hanga 55 · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT06546670Methylphenidate to Address Attention and Executive Deficits Among Children With Sickle Cell Disease
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 8 hanga 17 · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT07226219SCD Stem Cell Mobilization and Apheresis Using Motixafortide
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 08-Ful-2026 · NCT06442761Partial Stem Cell Transplant for Sickle Cell Disease From Matched Donors
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 4 hanga 65 · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT07599176Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 5 hanga 20 · Saalaa hunda · Haaromfame 02-Ful-2026 · NCT07369024Escalating Doses of VAS-101 in Subjects With Stable Sickle Cell Disease
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 90 · Saalaa hunda · Haaromfame 24-Hag-2026 · NCT07566494Cerebrovascular Reactivity Measurements With High-Density Diffuse Optical Tomography
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
Umuriin 6 hanga 70 · Saalaa hunda · Haaromfame 20-Hag-2026 · NCT07776444A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
Namoota walitti qabaa jiraSadarkaa 2/3
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 18-Hag-2026 · NCT05431088Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.